ACH

SEC Filing Summary: Owens & Minor, Inc. (10-Q)

Business Context and Reporting Period

This is a Quarterly Report (Form 10-Q) for Owens & Minor, Inc., a distributor of medical and surgical supplies, for the period ended September 30, 2008. The filing covers the third quarter and the first nine months of 2008, comparing results to the same periods in 2007. The company operates primarily in the healthcare provider distribution and direct-to-consumer (DTC) distribution sectors.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 7.3% in Q3 and 6.1% for the nine months, driven by sales to existing and new customers, partially offset by declines in the acquired McKesson business and the DTC segment.
• Margin Expansion: Gross margin percentage improved by 13 basis points in Q3 and 17 basis points for the nine months, attributed to manufacturer price increases, higher sales of value-added services, and improved margins from the McKesson integration.
• Operating Expenses: SG&A expenses increased due to higher fuel costs, IT outsourcing fees, and incentive compensation. However, SG&A as a percentage of revenue improved for the nine-month period due to infrastructure leverage and the absence of one-time McKesson integration costs incurred in 2007.
• Interest Expense: Net interest expense decreased significantly for the nine months ($12.6M vs. $19.2M) due to lower average borrowings and favorable rates, partially offset by a $3.1 million loss on the termination of interest rate swaps in Q3.
• DTC Segment: The Direct-to-Consumer business reported operating losses of $0.3 million in Q3 and $1.8 million for the nine months, compared to earnings in 2007, due to lower Medicare reimbursements and higher contractual allowances.

Outlook, Risks, and Unusual Items

• Acquisition: On October 1, 2008, the company acquired The Burrows Company for $23.7 million in cash plus $56.1 million of assumed debt. The company borrowed approximately $80 million to fund this transaction.
• Derivative Termination: Following the bankruptcy of Lehman Brothers (a guarantor of the company's interest rate swaps), the company terminated its swap agreements in September 2008, realizing a $3.1 million loss. This reduced the company's borrowing capacity under its revolving credit facility from $350 million to $306 million.
• Regulatory Risk: The Medicare Improvements for Patients and Providers Act of 2008 is expected to reduce reimbursement rates for certain DTC products by 9.5% starting January 1, 2009, and has delayed the competitive bidding program.
• Liquidity: Cash from operations declined year-over-year due to increases in accounts receivable and inventory. The company maintains a $350 million revolving credit facility (reduced to $306 million effective Oct 1) with approximately $339 million available at period end.
• Accounting Correction: The company corrected immaterial errors in prior filings regarding the classification of bank overdrafts, revising the December 31, 2007 balance sheet and 2007 cash flow statement. This did not impact net income or equity.

Investor Verification Checklist

• Verify the impact of the 9.5% Medicare reimbursement cut on the DTC segment's profitability in 2009.
• Monitor the integration progress and financial contribution of The Burrows Company acquisition.
• Assess the company's ability to maintain liquidity given the reduction in credit facility capacity due to Lehman Brothers' default.
• Review the trend in Days Sales Outstanding (DSO), which improved to 23.8 days, to ensure receivables collection remains efficient.
• Confirm the status of the pending real estate purchase related to the Burrows acquisition (expected completion by year-end 2008).